PTPI

Petros Pharmaceuticals, Inc. NASDAQ Listed Dec 2, 2020

Healthcare ·Drug Manufacturers - Specialty & Generic ·US · petrospharma.com

$0.01

+0.00% vs $0.01

Mkt Cap $186,961

52w Low $0.00 10.5% of range 52w High $0.04

50d MA $0.01 200d MA $0.01

P/E (TTM) 0.0x

EV/EBITDA —

P/B 0.0x

Debt/Equity 0.0x

ROE -148.9%

P/FCF -0.0x

RSI (14) 0.00

ATR (14) $0.00

Beta 1.66

50d MA $0.01

200d MA $0.01

Avg Volume 80.8K

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.

CIK (SEC)

1815903

Phone

973-242-0005

1185 Avenue of the Americas · New York City, NY 10036 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Nov 13, 2025	AMC	—	-0.03	—	0.02	+5.9%	+0.0%	-11.8%	-6.7%	+0.0%	+0.0%	—
Aug 14, 2025	AMC	—	-1.58	—	0.03	+0.0%	+0.0%	-3.2%	-3.3%	+3.4%	-6.7%	—
May 15, 2025	AMC	—	-8.46	—	0.16	-6.2%	-16.8%	-0.8%	-6.1%	-46.8%	-28.8%	—
Mar 31, 2025	AMC	-8.25	-29.00	-251.5%	1.73	-10.4%	+21.4%	-14.3%	-5.0%	-1.8%	-6.5%	—
Nov 13, 2024	AMC	-0.29	-13.25	-4469.0%	7.09	-1.3%	-4.7%	-4.1%	+1.2%	-4.3%	-1.6%	—
Aug 14, 2024	AMC	-0.77	-9.25	-1101.3%	7.82	+8.7%	+8.1%	+2.1%	+3.2%	+4.0%	-6.9%	—
May 31, 2024	AMC	—	0.13	—	15.35	+5.9%	-15.4%	-2.3%	-9.7%	+9.0%	-3.4%	—
May 15, 2024	AMC	-1.44	-51.25	-3459.0%	12.89	+6.3%	+6.3%	+6.9%	+6.6%	+4.0%	+0.1%	—
Nov 15, 2023	AMC	—	-57.75	—	33.25	+2.3%	-6.0%	+2.4%	+2.3%	+0.8%	-3.8%	—
Aug 14, 2023	AMC	—	-30.00	—	79.25	+1.9%	+0.9%	-3.1%	-1.3%	-6.9%	+4.6%	—
May 15, 2023	AMC	—	-16.50	—	105.00	-4.8%	+3.3%	+3.9%	-6.0%	-2.1%	-10.1%	—
Apr 7, 2023	AMC	—	-7.20	—	—	—	—	—	—	—	—	—

Data updated apr 28, 2026 6:35pm · Source: financialmodelingprep.com